Is Circulation Research a Good Journal? Impact, Scope, and Fit
Circulation Research (IF 16.2, AHA) is the top journal for basic and translational cardiovascular science. Here is who should submit and how it compares to Circulation, EHJ, and JACC.
Research Scientist, Neuroscience & Cell Biology
Author context
Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.
Journal fit
See whether this paper looks realistic for Circulation Research.
Run the Free Readiness Scan with Circulation Research as your target journal and see whether this paper looks like a realistic submission.
Circulation Research at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 16.5 puts Circulation Research in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~10% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Circulation Research takes ~21-35 days. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to read Circulation Research as a target
This page should help you decide whether Circulation Research belongs on the shortlist, not just whether it sounds impressive.
Question | Quick read |
|---|---|
Best for | Circulation Research isn't looking for clinical trials or patient outcomes data - that's Circulation's. |
Editors prioritize | Mechanistic depth over phenomenology |
Think twice if | Submitting clinical or epidemiological studies |
Typical article types | Original Research Article, Brief Communication, Compendium Reviews |
Circulation Research (IF 16.2, AHA, Q1 Cardiac and Cardiovascular Systems) is the premier journal for basic and translational cardiovascular science. The critical distinction for your submission: this is NOT a clinical journal. That is Circulation.
This is the most commonly confused decision in cardiovascular publishing. Circulation (IF 38.6) publishes clinical research - trials, outcomes, epidemiology. Circulation Research publishes mechanisms - how cardiovascular biology works at the molecular, cellular, and systems level. If your paper measures patient outcomes, it belongs at Circulation. If it explains a cardiovascular pathway with causal evidence, Circulation Research is the target.
Circulation Research at a Glance
Metric | Detail |
|---|---|
Impact Factor (2024) | 16.2 |
Publisher | AHA (American Heart Association) |
Quartile | Q1 (Cardiac and Cardiovascular Systems) |
Acceptance Rate | ~10-15% |
Format | Original Research, Brief Communications, Reviews |
Open Access APC | ~$5,450 (hybrid) |
Review Speed | 6-10 weeks typical |
Key Strength | Mechanistic cardiovascular biology with causal rigor |
How Circulation Research Compares to Peer Journals
Feature | Circulation Research | Circulation | European Heart Journal | JACC |
|---|---|---|---|---|
IF (2024) | 16.2 | 38.6 | 39.3 | 21.0 |
Scope | Basic/translational CV science | Clinical CV research | Broad clinical cardiology | Clinical cardiology + imaging |
Primary Audience | CV basic scientists | Clinical cardiologists | European cardiology | US/global cardiology |
What It Wants | Causal mechanism | Patient outcomes | Clinical practice | Clinical practice + innovation |
Publisher | AHA | AHA | ESC | ACC |
The four-journal comparison clarifies the landscape. Circulation Research is the only one of these that is fundamentally a basic science journal. Circulation, EHJ, and JACC are all clinical. If your paper explains cardiovascular biology mechanistically, Circulation Research is the natural home. If it reports what happens in patients, it belongs in one of the clinical flagships.
What Circulation Research Editors Actually Select
The editorial filter asks: does this paper explain how cardiovascular biology works, with enough rigor and orthogonal evidence to be durable?
Papers that succeed here share these traits:
- Mechanism is ahead of description - the paper explains why, not just what
- The cardiovascular relevance is intrinsic to the biology, not grafted on for scope
- The central claim is tested with multiple independent lines of evidence (not one model, one assay, one readout)
- The advance changes how the field understands a pathway, cell type, or disease process
The most common failure mode is interesting cardiovascular phenotype work where the mechanism is still underdeveloped. Circulation Research wants the mechanism to be the main event, not a promise for future work.
Submit If / Think Twice If
Submit if:
- Your paper explains a cardiovascular mechanism with causal evidence across multiple models or approaches
- The cardiovascular relevance is inherent to the biology, not added for framing
- Removing all clinical language would still leave an important mechanistic story
- The advance changes how the field understands a cardiovascular pathway or process
Think twice if:
- The paper reports clinical outcomes, epidemiological associations, or trial results - Circulation, EHJ, or JACC are the correct targets
- The phenotype is interesting but the causal mechanism is still too thin - one more set of experiments may be needed
- The central claim depends on one inhibitor, one model, or one descriptive dataset
- The work is good cardiovascular biology but the audience is really vascular biology specialists - ATVB (IF ~7.4) may be a truer fit
Journal fit
See whether this paper looks realistic for Circulation Research.
Run the scan with Circulation Research as the target. Get a manuscript-specific fit signal before you commit.
Frequently Asked Questions
Is Circulation Research more prestigious than Cardiovascular Research?
Yes, by most conventional measures. Circulation Research (IF 16.2) is the AHA's basic science flagship and is more selective than Cardiovascular Research (IF ~10.2, ESC-affiliated). However, Cardiovascular Research is a strong journal and sometimes the better fit for translational or European-audience work.
Can I submit a translational paper to Circulation Research?
Yes - but the mechanism must dominate. If 60% of the paper explains the mechanism and 40% shows translational relevance, it fits. If the ratio is reversed, Circulation or a clinical journal is the better target.
What about vascular biology specifically?
The AHA publishes Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB, IF ~7.4) for focused vascular biology. Circulation Research takes vascular papers when the mechanistic advance is broad enough to matter across cardiovascular science, not just within the vascular niche.
Does Circulation Research publish reviews?
Yes - both invited and unsolicited review articles. The journal's review section (including Compendium articles) is well-regarded for authoritative mechanistic summaries.
Bottom Line
Circulation Research is the top basic science cardiovascular journal - the place where mechanistic cardiovascular biology with strong causal evidence belongs. The decision is straightforward: if your paper explains how cardiovascular biology works (mechanism), submit here. If it shows what happens in patients (outcomes), submit to Circulation. Do not confuse the two.
Before submitting, a Circulation Research scope and readiness check can help you assess whether the mechanistic depth and multi-line evidence match what Circulation Research editors expect.
Last Verified: JCR 2024 (IF 16.2, 5-yr IF 20.8, JCI 4.12, Q1, rank 2/98 in Cardiac & Cardiovascular Systems) cross-checked against AHA editorial policies.
Before you submit
A Circulation Research submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.
Circulation Research: basic cardiovascular science with the AHA
Circulation Research (AHA, IF ~16) is the premier journal for fundamental and translational cardiovascular biology. Editor-in-Chief Jane E. Freedman emphasizes mechanistic research using biochemistry, biophysics, cellular biology, molecular biology, genetics, pathology, physiology, and pharmacology relevant to the cardiovascular system.
Circulation Research does not publish clinical trials (those belong at Circulation or JACC) or epidemiology without mechanism. The journal wants to understand WHY cardiovascular disease occurs at the molecular and cellular level, not just THAT it occurs.
A special welcome is extended to translational research and clinical research that yields fundamental insights, studies in human tissues that advance understanding of disease basis and therapy mechanisms.
A Circulation Research desk-rejection risk check scores fit against the journal's editorial bar.
Frequently asked questions
Yes. Circulation Research (IF 16.2, AHA) is the premier journal for basic and translational cardiovascular science. It is the mechanistic counterpart to Circulation within the AHA journal family - publishing causal cardiovascular biology rather than clinical outcomes.
This is the most important distinction in the AHA family. Circulation (IF 38.6) publishes clinical cardiovascular research - trials, outcomes, epidemiology. Circulation Research (IF 16.2) publishes basic and translational cardiovascular biology - mechanisms, pathways, causal explanations. If your paper reports patient outcomes, submit to Circulation. If it explains how cardiovascular biology works, submit to Circulation Research.
Approximately 10-15%. The journal is highly selective and prioritizes manuscripts with deep mechanistic cardiovascular insight supported by multiple lines of evidence. Descriptive or single-assay studies are usually desk-rejected.
Yes, but the emphasis must remain on mechanism. Translational papers succeed here when the main contribution is understanding why a cardiovascular process works, not just demonstrating that a therapy is effective. If the center of gravity is the clinical application, Circulation or JACC is the better target.
Editorial triage decisions come within 1-2 weeks. Full peer review typically takes 6-10 weeks. The AHA review process is standard single-blind with 2-3 expert reviewers.
Sources
- 1. Circulation Research journal homepage, American Heart Association.
- 2. Circulation Research author guidelines, AHA.
- 3. Clarivate Journal Citation Reports (2024 release).
Final step
See whether this paper fits Circulation Research.
Run the Free Readiness Scan with Circulation Research as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Circulation Research Submission Guide: Requirements, Fit, and Editor Priorities
- How to Avoid Desk Rejection at Circulation Research (2026)
- Circulation Research Review Time: What Authors Can Actually Expect
- Circulation Research Impact Factor 2026: 16.2, Q1, Rank 2/98
- Circulation Research Submission Process: What Happens After You Upload
- Circulation Research Cover Letter: What Editors Actually Need to See
Supporting reads
Conversion step
See whether this paper fits Circulation Research.
Anthropic Privacy Partner. Zero-retention manuscript processing.